Truist cuts James Hardie stock price target on homebuilding outlook

Truist Securities reduced its price target for James Hardie (JHX) to $37 from $40, citing weaker North American homebuilding outlook. The company's Q2 FY2027 results beat expectations, but guidance was in line. JHX stock has a 65% return over the past year and a P/E ratio of 109. Other analysts have mixed views, with some revising earnings downwards and others raising price targets. The company also announced the sale of its European business for $980 million.

Original reporting
Published Nov 6, 2026, 1:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 2:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$JHX
Bearish
medium confidence
Mentioned
$JHX
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$JHXBearishMed
01

Why it matters

The combination of a price‑target cut and strategic divestiture creates mixed signals for the stock.

02

Market read

Analyst downgrade may drive short‑term weakness, while strategic moves could support longer‑term outlook.

03

What to watch

Recent revenue and EBITDA guidance upgrades and the sale of the European business could offset the downside.

Relevance 5/10Novelty 5/10Timing: today

Background

James Hardie reported Q2 FY2027 results above expectations and announced the sale of its European walling business to Holcim.

Company-level read

Ticker impact

$JHXBearishMedium confidence
Context

Truist Securities lowered its price target on James Hardie Industries to $37 from $40, citing weaker North American new construction outlook.

Expected impact

likely downward pressure as the market prices in the reduced target

Evidence & confidence

The price‑target cut is a fresh analyst action that can trigger short‑term selling.

Market effects

The downgrade reflects concerns about the North American construction sector, which may affect other building‑materials companies.

Potential negative sentiment for U.S. construction‑related stocks.

Limited to the building‑materials sector; no broad market impact.

Counterpoint

Some investors may view the lower target as an entry point if they believe the construction outlook will improve.

Key entities

  • James Hardie Industries

    Building‑materials manufacturer listed on NYSE (JHX).

  • Truist Securities

    Equity research firm that lowered the price target.

Related articles

$JHXMedAI 8/10

What James Hardie Industries (JHX) Said on Its Q2 Earnings Call

James Hardie Industries (JHX) reported Q2 sales growth of 15% in siding and trim to $880M, and 51% in deck, rail & accessories to $387M. The company maintained its fiscal 2027 sales and EBITDA guidance. It raised its full-year free cash flow target to over $650M and repaid $111M in debt. Management expects cost pressures at the high end of its prior range.

$JHXHighAI 9/10

Why is James Hardie Industries stock sliding today?

James Hardie Industries PLC ADR stock fell 1.7% in pre-market trading after its Q2 earnings beat estimates but its revenue outlook fell short. Management revised its full-year housing market assumption to a mid-single-digit decline. Analysts cut price targets, with Citi downgrading the stock to Neutral. The broader market is mixed, offering no sector-wide support.

$JHXHighAI 8/10

James Hardie: Fiscal Q2 Earnings Snapshot

James Hardie Industries PLC (JHX) reported fiscal Q2 profit of $151M, or 26 cents per share, with adjusted earnings of 42 cents per share, beating analyst estimates. Revenue was $1.43B, also surpassing forecasts. The company expects Q3 revenue of $1.06B-$1.14B and full-year revenue of $4.99B-$5.13B.

$JHXHighAI 8/10

James Hardie falls on disappointing fiscal 2027 outlook

James Hardie (JHX) beat Q2 earnings and revenue estimates but shares fell 7.9% after-hours due to weak Q3 and FY2027 guidance. Revenue grew 24% YoY to $1.428B, but full-year outlook was below expectations. CEO cited strong sales and margin expansion. The company reduced debt and raised its free cash flow target.